For patients with the BRAF V600E mutation, the mortality risk significantly increases with each additional year of age, with HR values ranging from 1.03 in papillary thyroid carcinoma (PTC) to 1.05 in medullary thyroid carcinoma (MTC). The gene discussed is BRAF; the disease is differentiated thyroid carcinoma.